Novel Drug From Neuro-Bio Effective in a Mouse Model of Alzheimer's Disease - Press Release

NBP14 Targets Possible Primary Driver of Neurodegeneration Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegen

Related Keywords

United Kingdom ,London ,City Of ,Gregory Cole ,Paull Herrling ,Martin Rossor ,King College London ,Alzheimer Center ,Global Head Of Research Novartis Pharma ,Fbio Ltd ,Professor Baroness Greenfield At Oxford University ,Oxford University ,Medicines Healthcare Products Regulatory Agency ,Translational Research Clinical Interventions ,Possible Primary Driver ,Translational Research ,Clinical Interventions ,College London ,Professor Susan Greenfield ,Global Head ,Novartis Pharma ,Non Executive Director ,Healthcare Products Regulatory Agency ,Innovation Passport ,Associate Director ,Professor Baroness Greenfield ,Neuro Bio Ltd ,